Stevanato Group S.p.A. (NYSE:STVN) Shares Sold by Hilltop National Bank

Hilltop National Bank trimmed its stake in Stevanato Group S.p.A. (NYSE:STVN) by 10.6% in the fourth quarter, HoldingsChannel.com reports. The fund owned 4,553 shares of the company’s stock after selling 540 shares during the quarter. Hilltop National Bank’s holdings in Stevanato Group were worth $99,000 at the end of the most recent reporting period.

Other institutional investors also recently made changes to their positions in the company. nVerses Capital LLC purchased a new stake in shares of Stevanato Group in the third quarter valued at $84,000. Hardy Reed LLC lifted its stake in shares of Stevanato Group by 8.2% in the third quarter. Hardy Reed LLC now owns 11,077 shares of the company’s stock worth $222,000 after acquiring an additional 840 shares in the last quarter. Lindenwold Advisors INC lifted its stake in shares of Stevanato Group by 13.5% in the third quarter. Lindenwold Advisors INC now owns 11,930 shares of the company’s stock worth $239,000 after acquiring an additional 1,415 shares in the last quarter. Oppenheimer Asset Management Inc. lifted its stake in shares of Stevanato Group by 59.2% in the second quarter. Oppenheimer Asset Management Inc. now owns 11,941 shares of the company’s stock worth $219,000 after acquiring an additional 4,441 shares in the last quarter. Finally, Raymond James Trust N.A. raised its stake in Stevanato Group by 22.6% during the third quarter. Raymond James Trust N.A. now owns 12,556 shares of the company’s stock valued at $251,000 after buying an additional 2,317 shares in the last quarter.

Stevanato Group Price Performance

STVN opened at €22.92 ($23.39) on Friday. The stock has a fifty day moving average of €21.24 and a 200-day moving average of €20.21. The firm has a market capitalization of $6.77 billion, a P/E ratio of 48.77, a PEG ratio of 10.49 and a beta of 0.56. Stevanato Group S.p.A. has a 12-month low of €16.56 ($16.90) and a 12-month high of €34.73 ($35.44). The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of €0.13 ($0.13) by (€0.01) (($0.01)). The firm had revenue of €277.90 million for the quarter, compared to analysts’ expectations of €274.36 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. Stevanato Group’s revenue was up 2.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.16 earnings per share. Equities analysts forecast that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the company. Morgan Stanley reiterated an “equal weight” rating and set a $23.00 price target (down from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. Wolfe Research began coverage on Stevanato Group in a research note on Friday, December 13th. They set an “outperform” rating and a $28.00 price target for the company. Finally, Bank of America increased their price target on Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a research note on Friday, December 13th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, Stevanato Group has a consensus rating of “Moderate Buy” and an average price target of €28.60 ($29.18).

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.